NCA033989 Trial - 3rd Infusion Update (ET+CALR1) - MPN Voice

MPN Voice

11,202 members15,695 posts

NCA033989 Trial - 3rd Infusion Update (ET+CALR1)

Zeppelin11 profile image
5 Replies

Good morning! I'm happy to report that I had my third infusion last week, and my platelets are at 265,000 and seem to be stabilizing. My WBC, RBC, and LDH levels are normal, and my RDW is almost within the normal range as well!

Currently, my regimen is 750mg every two weeks, and I'll continue this indefinitely. Before the trial, my platelets were over 1 million. Over the last three weeks, as my numbers have normalized, I've noticed a significant increase in energy, a decrease in spleen size (I don't get full as quickly when I eat), and reduced brain fog, leading to more clear-headedness.

My next infusion is a week from tomorrow, at which point I will provide another update. I also plan to ask my doctors for the latest information on the trial, especially now that they've been approved to start patients at a higher dose, given the lack of significant side effects observed so far.

I'm very pleased with the results thus far. I try not to get ahead of myself, but I've been through 3 medications in 8 years and haven't seen these numbers since before I was diagnosed. Hoping for regression in my BMB in August, however I know this will take time. Chat soon!

Written by
Zeppelin11 profile image
Zeppelin11
To view profiles and participate in discussions please or .
Read more about...
5 Replies
dbus1417 profile image
dbus1417

awesome news. Thank you again for sharing and participating. 🥳

hunter5582 profile image
hunter5582

Great news! Thanks for keeping us up to date on this promising new option.

EPguy profile image
EPguy

The new stage of the trial you refer may be "Experimental: Part 1b" in the "study plan" of:

clinicaltrials.gov/study/NC...

This is a good sign there are no signif safety signals in the cohort. If your results are typical this agent is likely to qualify for a set of FDA procedures, below, that can bring it to market faster since it looks to address some currently unsolvable issues. (assuming the FDA is allowed to keep functioning)

--

Types of special FDA status:

Priority Review

Breakthrough Therapy

Accelerated Approval

Fast Track

fda.gov/patients/learn-abou...

socrates_8 profile image
socrates_8

Hey Zeppelin11...

Those results are sounding nothing short of spectacular...

In Australia, similar CTs are at a similar stage, as I understand things...

Being CALR (2) myself naturally I am also most interested in the progress of these Trials...

Thanks so much for Posting! Wishing you ongoing & continued success, which appears on the surface to be remarkable outcomes. Thanks for keeping us all in the loop too...

Best wishes

Steve

(Sydney)

ETket profile image
ETket

It all sounds like it's going really well! :-)

Not what you're looking for?

You may also like...

NCA033989 Trial - 2nd Infusion Update

On Monday, I had my second infusion. My pre-lab results showed my platelets at 326,000 and my LDH...
Zeppelin11 profile image

Started INCA033989 Trial at Stanford | 40 Years Old w/ ET-CALR1

Hello Friends, After careful consideration, I decided to join this trial. Since I was diagnosed in...
Zeppelin11 profile image

Update on Pegasys for ET

After just 6 weeks on Pegasys my platelets are down from 1150 to 450, which my haem and I are both...
AndyT profile image

Thrombocytosis…..ET? UPDATE

Hi everyone, so it’s been over a year since my last post and in that time my high platelets saga is...
Purdy13 profile image

Besremi Trial update

Apologies for the long post. I have learned so much from this site so I would like to share my...
CLake4 profile image

Moderation team

Debinha profile image
DebinhaAdministrator
Mazcd profile image
MazcdPartner

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.